Health2 days ago
FDA Grants Breakthrough Status to Incyte’s Blood Cancer Treatment
Incyte Corporation announced on October 22, 2023, that the U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy designation to its experimental drug, INCA033989. This...
